A new study has found that SGLT-2 inhibitor drugs for type 2 diabetes may also reduce the risk of kidney stones and gout. These painful conditions are ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Gout causes sudden flares of joint pain, which often arise during the nighttime, and in the big toe, though it may affect other joints including the ankles | Genetics And Genomics ...

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...

While gout is commonly linked to excessive drinking or poor diet, new research has revealed that genetics may play a larger ...

The FDA has just dropped a truth bomb: if you’ve been relying on those familiar red pills for a stuffy nose, it might be time ...

In the complex landscape of reproductive health, emergency contraception stands as a critical option for individuals seeking ...

Turmeric is touted as a cure-all spice but nutrition experts are more cautious about recommending turmeric for everything.

Gout affects around one in 40 people in developed ... while others are intolerant to the drugs. Sobi’s filing is based on the DISSOLVE I and II pivotal studies, in which roughly half of the ...

We are actively planning a phase II clinical trial of PRX-115 in gout patients and expect to initiate the study ... having reported study drug-related adverse events, the majority of which were mild ...